(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202209 | 202109 | % Var | 202209 | 202109 | % Var | 202203 | 202103 | % Var | |
| Sales | 46.17 | 21.42 | 115.55 | 71.04 | 60.35 | 17.71 | 143.51 | 101.72 | 41.08 |
| Other Income | 0.09 | 0.00 | 0.00 | 0.10 | 0.32 | -68.75 | 0.00 | 0.00 | 0.00 |
| PBIDT | 5.76 | -1.76 | -427.27 | 6.41 | 3.43 | 86.88 | 5.09 | 3.58 | 42.18 |
| Interest | 0.07 | 0.06 | 16.67 | 0.08 | 0.10 | -20.00 | 1.32 | 1.73 | -23.70 |
| PBDT | 5.69 | -1.82 | -412.64 | 6.33 | 3.33 | 90.09 | 3.77 | 1.85 | 103.78 |
| Depreciation | 0.19 | 0.20 | -5.00 | 0.39 | 0.40 | -2.50 | 0.76 | 0.81 | -6.17 |
| PBT | 5.50 | -2.02 | -372.28 | 5.94 | 2.93 | 102.73 | 3.01 | 1.04 | 189.42 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.47 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 5.50 | -2.02 | -372.28 | 5.94 | 2.93 | 102.73 | 2.54 | 1.04 | 144.23 |
| Equity | 44.81 | 44.81 | 0.00 | 44.81 | 44.81 | 0.00 | 44.81 | 44.81 | 0.00 |
| PBIDTM(%) | 12.48 | -8.22 | -251.83 | 9.02 | 5.68 | 58.76 | 3.55 | 3.52 | 0.78 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: